1. Wu, Jiao, Wang, Yunpeng, Jiang, Zheng. . TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer. In Journal of gastrointestinal cancer, 52, 150-159. doi:10.1007/s12029-020-00371-6. https://pubmed.ncbi.nlm.nih.gov/32077004/
2. Wu, Jiao, Wang, Yunpeng, Yang, Yichun, Jiang, Zhongxiang, Jiang, Zheng. 2021. TNFSF9 promotes metastasis of pancreatic cancer through Wnt/Snail signaling and M2 polarization of macrophages. In Aging, 13, 21571-21586. doi:10.18632/aging.203497. https://pubmed.ncbi.nlm.nih.gov/34517345/
3. Isoda, Bunpei, Kandori, Shuya, Sazuka, Tomokazu, Ichikawa, Tomohiko, Nishiyama, Hiroyuki. 2024. TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab. In International journal of molecular sciences, 25, . doi:10.3390/ijms25137444. https://pubmed.ncbi.nlm.nih.gov/39000552/